Table 1.
Clinical characteristics of human samples.
| Sample characteristics | Group1 (CHB patients without treatment) | Group2 (CHB patients achieving SVR) | Group3 (healthy donors) |
|---|---|---|---|
| Number of patients | 79 | 20 | 59 |
| Age (years; median, range) | (41, 50) | (51, 38) | (33, 54) |
| Gender (male/female) | (52/27) | (14/6) | (37/22) |
| HBeAg (negative/positive) | (35/44) | (20/0) | (59/0) |
| HBV DNA (IU/ml; >103/<103) | (50/29) | (0/20) | (0/59) |
| HBsAg (negative/positive) | (0/79) | (0/20) | (59/0) |
| HBsAb (negative/positive) | (79/0) | (20/0) | (0/59) |
| ALT (U/l; ≤42/>42) | (37/42) | (20/0) | (59/0) |
HBsAg, hepatitis B surface antigen; HBeAg, hepatitis B e antigen; HBsAb, hepatitis B surface antibody; CHB, chronic hepatitis B; SVR, sustained virological response.